Skip to main content

Table 4 Summarized results of validation on the test cohort.

From: Predictors of primary breast cancers responsiveness to preoperative Epirubicin/Cyclophosphamide-based chemotherapy: translation of microarray data into clinically useful predictive signatures

 

Predicted response k-NN

Predicted response PLS-DA; model 1

Predicted response PLS-DA; model 2

predicted CR

7

9

10

other

20

18

17

predicted PR

9

4

9

other

18

23

18

predicted NC

11

14

8

other

16

13

19

Sensitivity CR

100

100

100

Specificity CR

87

78

74

PPV

57

44

40

NPV

100

100

100

Sensitivity PR

53

24

35

Specificity PR

100

100

100

PPV

100

100

67

NPV

56

43

39

Sensitivity NC

100

100

50

Specificity NC

76

62

76

PPV

55

43

38

NPV

100

100

84